by The global consumer genomics market size was valued at USD 2.87 billion in 2022 and is projected to reach USD 17.51 billion by 2032, growing at a CAGR of 19.82% from 2023 to 2032, According to Precedence Research.
The global consumer genomics market boons an in-depth synopsis of the competitive landscape of the market globally, thus helping establishments understand the primary threats and prospects that players/vendors in the market are dealt with. It also incorporates thorough business profiles of some of the prime vendors in the market.
Download The Sample Copy For Better Understanding@https://www.precedenceresearch.com/sample/3018
Consumer Genomics Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 3.44 Billion |
| Market Size by 2032 | USD 17.51 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 19.82% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Applications |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Also read: Automotive Films Market Size To Rake USD 13.56 Bn By 2032
Benefits of this market
- This study analyses the market size and share for consumer genomics along with the present trends in the industry and forecasts for the future, showing investment opportunities for the future.
- In order to compare the financial capabilities of the consumer genomics market in the present, a quantitative analysis is done of the market from 2023 to 2032.
- It is clear from this brilliant presentation of Porter’s Five Forces that buyers and suppliers have a lot of potential to gain from one another.
- It is important to understand the most profitable trends in the consumer genomics market in order to gain an advantage in the market.
- A comprehensive analysis of the driving factors, limitations, and opportunities is provided in the report, along with an in-depth analysis of the effect they have on the market.
- The report also includes the market share for consumer genomics for several significant vendors as well as the latest developments in the market.
Leading players of the global consumer genomics market are analysed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. Precedence Research provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global consumer genomics market. Furthermore, the report offers two separate market forecasts – one for the production side and another for the consumption side of the global consumer genomics market. It also provides useful recommendations for new as well as established players of the global consumer genomics market.
The major players in the market
- Ancestry
- Gene By Gene, Ltd. (FamilyTree DNA)
- 23andMe, Inc.
- Color Genomics, Inc.
- Myriad Genetics, Inc.
- Mapmygenome
- Positive Biosciences, Ltd.
- Futura Genetics
- Helix OpCo LLC
- MyHeritage Ltd.
- Pathway Genomics
- Amgen, Inc.
- Xcode Life
- Diagnomics, Inc.
- Toolbox Genomics
- SomaLogic, Inc.
- Inui Health (formerly Scanadu)
- AgeCurve
- QuickCheck Health
- Biomeb
Consumer Genomics Market Segmentations:
By Applications
- Genetic Relatedness
- Diagnostics
- Lifestyle, Wellness, & Nutrition
- Ancestry
- Reproductive Health
- Personalized Medicine & Pharmacogenetic testing
- Sports Nutrition & Health
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Consumer Genomics Market
5.1. COVID-19 Landscape: Consumer Genomics Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Consumer Genomics Market, By Applications
8.1. Consumer Genomics Market, by Applications Type, 2023-2032
8.1.1. Genetic Relatedness
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Diagnostics
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Lifestyle, Wellness, & Nutrition
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Ancestry
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Reproductive Health
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Personalized Medicine & Pharmacogenetic testing
8.1.6.1. Market Revenue and Forecast (2020-2032)
8.1.7. Sports Nutrition & Health
8.1.7.1. Market Revenue and Forecast (2020-2032)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Consumer Genomics Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Applications (2020-2032)
9.1.2. U.S.
9.1.2.1. Market Revenue and Forecast, by Applications (2020-2032)
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Applications (2020-2032)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Applications (2020-2032)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Applications (2020-2032)
9.2.3. Germany
9.2.3.1. Market Revenue and Forecast, by Applications (2020-2032)
9.2.4. France
9.2.4.1. Market Revenue and Forecast, by Applications (2020-2032)
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Forecast, by Applications (2020-2032)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Applications (2020-2032)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Applications (2020-2032)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Applications (2020-2032)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Applications (2020-2032)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Applications (2020-2032)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Applications (2020-2032)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Applications (2020-2032)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Applications (2020-2032)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Applications (2020-2032)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Applications (2020-2032)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Applications (2020-2032)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Applications (2020-2032)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Applications (2020-2032)
Chapter 10. Company Profiles
10.1. Ancestry
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Gene By Gene, Ltd. (FamilyTree DNA)
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. 23andMe, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Color Genomics, Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Myriad Genetics, Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Mapmygenome
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Positive Biosciences, Ltd.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Futura Genetics
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Helix OpCo LLC
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. MyHeritage Ltd.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Key inquiries addressed in the report:
- Investigate the COVID 19 outbreak’s effects.
- Our researchers give precise responses, pinpoint significant chances and fresh investments, and suggest excellent market strategy avenues.
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
